Opioid Peptide Genes Help Guide Heart Development in Embryonic Stem Cells
Opioid peptide gene expression (prodynorphin and proenkephalin) was found to precede and promote heart cell development in embryonic stem cells, revealing an unexpected developmental role for the opioid system.
Quick Facts
What This Study Found
Opioid peptide gene expression (prodynorphin, proenkephalin) preceded cardiac transcription factor activation (GATA-4, Nkx-2.5) during cardiogenesis in embryonic stem cells, suggesting opioid peptides prime heart cell development.
Key Numbers
How They Did This
In-vitro study using embryonal pluripotent stem cells differentiating into cardiomyocytes. Gene expression timeline for opioid peptides and cardiac transcription factors measured during DMSO-induced differentiation.
Why This Research Matters
Understanding what signals drive heart cell development could improve cardiac regenerative medicine. The opioid system's involvement adds an entirely new dimension to cardiac development biology.
The Bigger Picture
The opioid system's role in heart development raises questions about how opioid exposure during pregnancy might affect fetal heart formation — relevant to the opioid crisis's impact on neonatal health.
What This Study Doesn't Tell Us
In-vitro stem cell model using DMSO differentiation. Gene expression timing doesn't prove causation. Human cardiac development may differ from cell culture models.
Questions This Raises
- ?Do opioid drugs during pregnancy affect fetal heart development?
- ?Can opioid peptides be used to improve cardiac cell generation for regenerative medicine?
- ?Which opioid receptor mediates the cardiogenic priming?
Trust & Context
- Key Stat:
- Opioids before heart genes Prodynorphin and proenkephalin expression preceded cardiac transcription factors, suggesting opioid peptides prime the heart development program
- Evidence Grade:
- Preliminary in-vitro evidence from a stem cell differentiation model with clear temporal gene expression data, but causation not established.
- Study Age:
- Published in 2000. The developmental roles of opioid peptides have been further explored, with implications for understanding birth defects and regenerative medicine.
- Original Title:
- Opioid peptide gene expression primes cardiogenesis in embryonal pluripotent stem cells.
- Published In:
- Circulation research, 87(3), 189-94 (2000)
- Authors:
- Ventura, C(3), Maioli, M
- Database ID:
- RPEP-00631
Evidence Hierarchy
Frequently Asked Questions
Why are opioid genes active during heart development?
It suggests the opioid system helps guide stem cells toward becoming heart cells — a role no one expected. This could be important for making heart cells in the lab for regenerative medicine.
Does this mean opioid drugs affect heart development?
It raises the question. If opioid peptides naturally guide heart development, external opioid drugs during pregnancy could potentially interfere. This is especially relevant given the ongoing opioid crisis.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00631APA
Ventura, C; Maioli, M. (2000). Opioid peptide gene expression primes cardiogenesis in embryonal pluripotent stem cells.. Circulation research, 87(3), 189-94.
MLA
Ventura, C, et al. "Opioid peptide gene expression primes cardiogenesis in embryonal pluripotent stem cells.." Circulation research, 2000.
RethinkPeptides
RethinkPeptides Research Database. "Opioid peptide gene expression primes cardiogenesis in embry..." RPEP-00631. Retrieved from https://rethinkpeptides.com/research/ventura-2000-opioid-peptide-gene-expression
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.